Measure of Acceptance of chRonic Visible sKin conditionS

Last updated: October 24, 2023
Sponsor: University Hospital, Tours
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Questionnaire

Clinical Study ID

NCT06103903
MARKS
  • Ages > 6
  • All Genders

Study Summary

The objective of this protocol is to validate 4 scales for evaluating the acceptance of visible chronic dermatological diseases (port wine stains, alopecia areata, vitiligo, hyperpigmentation...) with a large number of patients (children, adolescents, adults) and their parents (depending on the composition of the family cluster), in a multicentric manner (for territorial representativeness).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Targeted pathologies:
  • Flat angioma
  • Primary hypopigmentation and early vitiligo
  • Primary hyperpigmentation
  • Refractory alopecia areata or congenital alopecia
  1. Persons concerned:
  • Children (≥ 6 years old) suffering from one of the aforementioned pathologies
  • Adults suffering from one of the above-mentioned pathologies
  • Parents of children suffering from one of the aforementioned pathologies
  • Parents of young adult patients if they live under the same roof
  1. Oral agreement for each person (major/minor) and, where applicable, one of the holdersof parental authority (minor)

Exclusion

Exclusion Criteria:

  1. Secondary "marks" (post-inflammatory, post-medication, post-traumatic, etc.)
  2. Major psychiatric disorders

Study Design

Total Participants: 250
Treatment Group(s): 1
Primary Treatment: Questionnaire
Phase:
Study Start date:
January 01, 2022
Estimated Completion Date:
December 31, 2025

Study Description

The objective of this protocol is to validate 4 scales for evaluating the acceptance of visible chronic dermatological diseases (port wine stains, alopecia areata, vitiligo, hyperpigmentation...) with a large number of patients (children, adolescents, adults) and their parents (depending on the composition of the family cluster), in a multicentric manner (for territorial representativeness).

The investigator will screen the patients and give them a link to complete the questionnaire (according to the age), that includes a pre-scale of acceptation of 50-55 items.

Connect with a study center

  • University Hospital TOURS

    Tours, 37044
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.